Wednesday, Jan 01, 2003
Download this FTI news release (PDF).

Fluorous Technologies Inc, (FTI) announced today that Mr. Walter E. Segl III would serve as the Vice President of Business Development.

Mr. Segl is responsible for the development of new business opportunities and the oversight of sales and marketing activities. He has spent over 20 years selling contract chemistry services, instrumentation, and consumables to the drug discovery market. Before joining FTI, Mr. Segl was Director, North America, Pharmaceutical Business Development for Discovery Partners. In this role he was directly responsible for developing and maintaining markets for four business units including ChemRx, DTL, IRORI, and Computational Discovery. Prior to the formation of DPI, Mr. Segl served as Director of Sales for IRORI. Additionally, he has held senior leadership positions at Thermo, Instron, and Beckman. Mr. Segl began his career in pharmaceutical research at Carter-Wallace where he was Group Leader, Analytical Methods Development. Mr. Segl received his B.S. in Biology from Albright College in 1980.

"Commercialization of our novel technology promises to solve one of the major bottlenecks in the field of organic synthesis facing chemists today. I look forward to joining the FTI management team and developing a customer focused sales organization from the ground up. Our pharmaceutical clients expect excellent service and I'm committed to helping FTI deliver it," Mr. Segl said.

"Walt brings exceptional experience and insight to the company." said Dr. Philip Yeske, Acting President and COO of FTI. "We look forward to his contributions, particularly in the area of key account strategy."